Category Patents/Designs/Trade Secrets

WHO Issues Two Reports Detailing Global Problem Of Substandard And Falsified Medicines

The World Health Organization today issued two substantive reports on the problem of substandard and falsified medicines around the world, finding among other things that an estimated one in 10 medical products in low and middle income countries is either substandard or falsified.

Expert Panel Recommends That The WHO Move Forward On Transparency And Delinkage

On Monday, 27 November, the WHO published the recommendations of the overall programme review of the global strategy and plan of action on public, health innovation and intellectual property (EB142/14). The expert panel provided 33 recommendations which included 17 forward looking”high-priority actions” including on transparency and delinkage, writes Thiru Balasubramaniam.

Industry Urges UK, EU, To Safeguard Medicines Regulation During Post-Brexit Transition

Associations representing the life sciences industry in the United Kingdom and Europe today issued a call for cooperation on regulation between the UK and European Union on medicines regulation.

TWN – Proposed WHO Criteria On Medicines In Transit Open Door For Seizures

Geneva, 21 Nov (TWN) - A discussion document prepared by the Secretariat of the World Health Organization (WHO) proposes criteria to justify interventions with respect to medicines in transit. This document is prepared for the 6th meeting of the Member State Mechanism (MSM) to be held from 28 November to 1 December at the WHO headquarters in Geneva, writes Third World Network.

International Court Of Justice Judges Getting Pulled Into Investor-State Cases

According to a study by a watchdog group released this week, numerous judges at the International Court of Justice (ICJ) have worked or are working on at least 90 investor-state dispute settlement cases, despite a prohibition on them doing work…

Buenos Aires Ministerial Not The End Of The Road, WTO Director Tells Reporters

The road to the World Trade Organization ministerial conference in Buenos Aires, Argentina, starting in a couple of weeks does not seem to be a walk in the park, as they say. WTO Director General Roberto Azevêdo, in a press briefing today [27 November], explained what can be expected from the 11th ministerial conference. He said consensus is escaping many issues, but Buenos Aires is not the end of the road, but rather one more step in the direction of trade liberalisation.

WIPO Development And IP Committee This Week: Agenda Includes Flexibilities, Tech Transfer, SDGs, Studies

Following a session in May hailed as the most positive in years, the World Intellectual Property Organization Committee on Development and Intellectual Property reconvenes this week. Among items to be discussed are a revised proposal by the African Group to convene a biennial international conference on IP and development, how to deal with the United Nations Sustainable Development Goals, and recommendations of an independent review of the implementation of the 2007 WIPO Development Agenda Recommendations.

Access To Affordable Healthcare: A Global Wake-Up Call Fosters Coalition Of The Like-Minded

NEW DELHI -- Few topics in the global health agenda are as contentious as access to affordable medicines and medical care, and expectedly, divergent views permeated the discussions at a high-level conference in New Delhi, India last week. But if there is one thing that the three-day meet made amply clear, it was this: access to affordable healthcare has emerged as a global problem, and an emerging coalition of the like-minded, cutting across the developed and developing countries, is determined to have their voices heard in international policy circles on the issue.

EPO: New Employment Rules Roil Staff; Management Responds On Demand For More Productivity

Outgoing European Patent Office President Benoȋt Battistelli has proposed a new “employment framework” that includes fixed-term contracts for patent examiners, reigniting anger among staff members already in a tense relationship with management. There is also concern that Battistelli’s apparent push – which the EPO denies - for more products (defined as prior art searches and proposals for patent grants) is hurting patent quality.